Cite Filings / SABS / 0000950170-22-010672

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

SAB Biotherapeutics, Inc. Filed 2022-05-25 Acc 0000950170-22-010672

Documents 1

DEF 14A Proxy Statement , sabs_def_14a_2022.htm

Around this filing

2023-05-19 DEF 14A Proxy Statement
2022-05-27 SC 13D/A Beneficial Ownership Report
2022-05-25 DEF 14A Proxy Statement
2022-05-23 4 Director acquired 299,002 shares (other)
2022-05-23 4 Executive Chairman disposed of 2,500,127 shares (other)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading sabs_def_14a_2022.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…